Charles Brynelsen net worth and biography

Charles Brynelsen Biography and Net Worth

Director of Envoy Medical

An accomplished healthcare executive, he served as Senior VP and President of Abbott Vascular (2017–2021) and Medtronic Early Technologies (2015–2016), and was the Global President of Covidien Early Technologies (2013–2015). Previously, he led IntraPace as CEO (2005–2012). Since 2015, he has been a Venture Partner at SpringRock Ventures, focusing on digital health and devices, and has served on boards like Alebra Technologies (since 2010) and Neuspera Medical (2022–2023). He holds an MBA from Northwestern's Kellogg School and a BA from Bradley University.

What is Charles Brynelsen's net worth?: The estimated net worth of Charles Brynelsen is at least $757.05 thousand as of February 12th, 2026. Mr. Brynelsen owns 1,050,000 shares of Envoy Medical stock worth more than $757,050 as of September 23rd. This net worth approximation does not reflect any other investments that Mr. Brynelsen may own. Learn More about Charles Brynelsen's net worth.
How do I contact Charles Brynelsen?: The corporate mailing address for Mr. Brynelsen and other Envoy Medical executives is 4875 White Bear Parkway, White Bear Lake, MN, 55110. Envoy Medical can also be reached via phone at (651) 361-8000 and via email at [email protected]. Learn More on Charles Brynelsen's contact information.
Has Charles Brynelsen been buying or selling shares of Envoy Medical?: Charles Brynelsen has not been actively trading shares of Envoy Medical over the course of the past ninety days. Most recently, on Thursday, February 12th, Charles Brynelsen bought 1,000,000 shares of Envoy Medical stock. The stock was acquired at an average cost of $0.40 per share, with a total value of $400,000.00. Following the completion of the transaction, the director now directly owns 1,050,000 shares of the company's stock, valued at $420,000. Learn More on Charles Brynelsen's trading history.
Who are Envoy Medical's active insiders?: Envoy Medical's insider roster includes Charles Brynelsen (Director), and Brent Lucas (Chief Executive Officer, Director). Learn More on Envoy Medical's active insiders.
Are insiders buying or selling shares of Envoy Medical?: In the last year, Envoy Medical insiders bought shares 6 times. They purchased a total of 20,433,650 shares worth more than $8,173,460.00. The most recent insider tranaction occured on February, 12th when Major Shareholder Glen A Taylor bought 18,750,000 shares worth more than $7,500,000.00. Insiders at Envoy Medical own 7.2% of the company. Learn More about insider trades at Envoy Medical.
Information on this page was last updated on 2/12/2026.

Charles Brynelsen Insider Trading History at Envoy Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/12/2026	Buy	1,000,000	$0.40	$400,000.00	1,050,000
5/27/2025	Buy	35,000	$1.65	$57,750.00	50,000
5/23/2025	Buy	13,000	$1.64	$21,320.00	15,000
5/22/2025	Buy	2,000	$1.68	$3,360.00	2,000

Charles Brynelsen Buying and Selling Activity at Envoy Medical

Envoy Medical Company Overview

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

Today's Range

Now: $0.72

$0.72

$0.73

50 Day Range

MA: $0.71

$0.64

$0.80

2 Week Range

Now: $0.72

$0.36

$1.89

Volume

33,571 shs

Average Volume

426,388 shs

Market Capitalization

$55.73 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.91